Laparoscopic Hepatectomy Surgery clinical trials

Explore recruiting laparoscopic hepatectomy surgery clinical trials.

Also recruiting in Europe

Laparoscopic Hepatectomy Surgery trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, transfusion requirement.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Laparoscopic Hepatectomy Surgery trials by city

Laparoscopic Hepatectomy Surgery in Toronto Laparoscopic Hepatectomy Surgery in Vancouver Laparoscopic Hepatectomy Surgery in Montreal Laparoscopic Hepatectomy Surgery in Calgary Laparoscopic Hepatectomy Surgery in Edmonton Laparoscopic Hepatectomy Surgery in Ottawa Laparoscopic Hepatectomy Surgery in Winnipeg Laparoscopic Hepatectomy Surgery in Quebec City Laparoscopic Hepatectomy Surgery in Hamilton Laparoscopic Hepatectomy Surgery in Kitchener Laparoscopic Hepatectomy Surgery in London Laparoscopic Hepatectomy Surgery in Halifax Laparoscopic Hepatectomy Surgery in New York Laparoscopic Hepatectomy Surgery in Los Angeles Laparoscopic Hepatectomy Surgery in Chicago Laparoscopic Hepatectomy Surgery in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease